Diabetic Kidney Disease Represents a Locus of Opportunity

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Frontiers in Physiology

• Publication date

  2021-03-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fphys.2021.650503PMID 33762972PMCID 7982870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toward Portable Artificial Kidneys: The Role of Advanced Microfluidics and Membrane Technologies in Implantable Systems

  2020cited by this paper
• How artificial kidneys and miniaturized dialysis could save millions of lives

  2020cited by this paper
• Bioengineering strategies for nephrologists: kidney was not built in a day

  2020cited by this paper
• Refining insulin signaling in the proximal tubule at the level of the substrate.

  2020cited by this paper
• Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

  2020cited by this paper
• Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype.

  2019cited by this paper
• MicroRNA: a novel biomarker and therapeutic target to combat autophagy in diabetic nephropathy.

  2019cited by this paper
• Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues

  2019cited by this paper
• Insulin promotes sodium transport but suppresses gluconeogenesis via distinct cellular pathways in human and rat renal proximal tubules.

  2019cited by this paper
• Clinical Practice: Mini-Review

  2019cited by this paper
• Kidney transplant wait list: Review and current trends

  2018cited by this paper
• Development of SGLT1 and SGLT2 inhibitors

  2018cited by this paper
• Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease

  2018cited by this paper
• JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

  2018cited by this paper
• Challenges of kidney paired donation transplants involving multiple donor and recipient surgeons across Australia

  2018cited by this paper
• Biomarkers of diabetic kidney disease

  2018cited by this paper
• Innovations in Wearable and Implantable Artificial Kidneys.

  2018influential reference
• Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

  2017cited by this paper
• Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients

  2017cited by this paper
• Diabetic Nephropathy: a Tangled Web to Unweave

  2017cited by this paper
• Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

  2017influential reference
• Renal, metabolic and cardiovascular considerations of SGLT2 inhibition

  2017cited by this paper
• Niclosamide: Beyond an antihelminthic drug

  2017cited by this paper
• Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

  2016cited by this paper
• Endoplasmic Reticulum Stress and Associated ROS

  2016cited by this paper
• C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

  2016cited by this paper
• Diabetic kidney disease: difference in the prevalence and risk factors worldwide

  2016cited by this paper
• Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies.

  2015cited by this paper
• Diabetic kidney disease: world wide difference of prevalence and risk factors

  2015cited by this paper
• Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy.

  2015cited by this paper
• Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

  2015cited by this paper
• Sodium-glucose cotransport

  2015cited by this paper
• The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.

  2015cited by this paper
• Can two be better than one? Dual RAS blockade in patients with type 2 diabetes and overt nephropathy in the age of ONTARGET and ALTITUDE

  2014cited by this paper
• Diabetes: Dual RAAS blocker trial stopped prematurely

  2013cited by this paper
• Effects of dual blockade of the renin–angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT–Hypertension)

  2013cited by this paper
• Pathophysiology of the diabetic kidney.

  2011cited by this paper
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2010cited by this paper
• Embryology of the Kidney

  2010cited by this paper
• Stem cells in the embryonic kidney.

  2008cited by this paper
• Reduced expression of insulin receptors in the kidneys of insulin-resistant rats.

  2007cited by this paper
• Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes.

  2007influential reference
• The effect of ruboxistaurin on nephropathy in type 2 diabetes.

  2005influential reference
• Nephropathy in diabetes.

  2004cited by this paper
• ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

  2003cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes.

  1992cited by this paper

• Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells

  2024cites this paper